Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
| Product: | Remsima |
| Active Ingredient: | Infliximab 100mg |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Celltrion Healthcare New Zealand Limited |
| Manufacturers: | Celltrion Inc., Incheon, South Korea Gensenta llac Sanayii ve Ticaret A.S., Instanbul, Turkey |
Dated this 30th day of May 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).